Highlights Inhibitor Therapeutics, Inc.

Equities

INTI

US45720M1053

Market Closed - OTC Markets Other stock markets 12:41:59 2024-05-15 EDT			5-day change	1st Jan Change
0.089 ^USD	-35.34%		-31.56%	-3.29%

03-29	Inhibitor Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Introducing Inhibitor Therapeutics, Inc. Announces Scientific Advisory Board	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Inhibitor Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-29	CI
Inhibitor Therapeutics, Inc. Announces the Use of Itraconazole to Treat Basal Cell Carcinoma Nevus Syndrome	12-19	CI
Inhibitor Therapeutics, Inc. Enters into an Exclusive, Worldwide Licensing Agreement with Johns Hopkins University	12-14	CI
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
Inhibitor Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12	CI
Inhibitor Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12	CI
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-13	CI
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-26	CI
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-16	CI
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-12	CI
Inhibitor Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-01	CI
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-30	CI
Inhibitor Therapeutics Inc. Receives Investigational New Drug Clearance from the U.S. Food and Drug Administration	20-01-22	CI
INHIBITOR Therapeutics Submits Investigational New Drug Application for Treatment of Patients with Late-Stage Prostate Cancer	19-11-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Inhibitor Therapeutics, Inc.

Equities

INTI

US45720M1053

Highlights

Filters